LARYNX GL D 30 ampoules

Pack size:

10 x 1 ml

Dosage form:

Ampoules

LARYNX GL D ampoules, which likely contains Glycopyrronium, are used in palliative care to manage excessive secretions and for injection laryngoplasty. In palliative care, it helps reduce drooling and other secretions. In injection laryngoplasty, it's used to address vocal cord issues like paresis, paralysis, atrophy, bowing, or scarring. 
Specifically, here's a breakdown of the uses:
Palliative Care:
Glycopyrronium (the likely active ingredient in LARYNX GL D) is used to manage excessive oral and respiratory secretions in palliative care settings. This can include drooling, which can be a distressing symptom for patients. The medication is typically administered via subcutaneous injection. 
Injection Laryngoplasty:
This procedure involves injecting a substance into the vocal cords to improve their position or function. Glycopyrronium, or a similar substance, may be used in this context to address various vocal cord problems. These problems can include: 
Vocal cord paresis or paralysis: Weakness or inability to move the vocal cords. 
Vocal cord atrophy: Thinning or wasting away of the vocal cords. 
Vocal cord bowing: An abnormal curvature of the vocal cords. 
Vocal cord scarring: Scar tissue on the vocal cords, which can affect their movement and vibration.